[ Price : $8.95]
FDA warns Castle Rock, CO-based Compounders International Analytical Laboratory about CGMP violations and deviations in its work t...[ Price : $8.95]
FDA publishes the 2025 OTC drug monograph forecast showing eight items it expects to address over the next three years.[ Price : $8.95]
FDA approves two new denosumab biosimilars from Shanghai Henlius Biotech and Organon for treating osteoporosis and cancer-related ...[ Price : $8.95]
Merck says its oral PCSK9 inhibitor met all primary and secondary endpoints in the CORALreef Lipids Phase 3 trial.[ Price : $8.95]
FDA releases the form FDA-483 with four observations from an inspection at the Las Vegas, NV-based AnazaoHealth compounding facili...[ Price : $8.95]
FDA policy and regulatory expert Steven Grossman warns that the agencys current trajectory risks undermining its effectiveness by ...[ Price : $8.95]
FDA warns Jackson, WI-based Wisconsin Pharmacal about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA agrees to accept a biosimilar application to compete with Johnson & Johnsons Stelara that does not include clinical efficacy s...